Münzel P A, Schmohl S, Heel H, Kälberer K, Bock-Hennig B S, Bock K W
Institute of Toxicology, University of Tübingen, Germany.
Drug Metab Dispos. 1999 May;27(5):569-73.
Human colon carcinoma Caco-2 cells were used to study the induction of UDP glucuronosyltransferase (UGT) isoforms UGT1A6, UGT1A9, and UGT2B7 by aryl hydrocarbon receptor agonists and by antioxidant-type inducers with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and t-butylhydroquinone (TBHQ), respectively. Early- (PF11) and late-passage clones (TC7) of Caco-2 cells, which show low and high constitutive UGT1A6 expression, respectively, were selected. The following results were obtained: 1) In Caco-2 cells UGT activity (4-methylumbelliferone as substrate) was significantly enhanced by 10 nM TCDD or 40 to 80 microM TBHQ and 2) duplex reverse-transcription-polymerase chain reaction analysis showed for the first time that the expression of human UGT1A6, UGT1A9, and UGT2B7 was enhanced by 40 to 80 microM TBHQ; both UGT1A6 and UGT1A9 were induced by 10 nM TCDD, whereas UGT2B7 was not induced by TCDD. The results suggest that at least two human UGTs (UGT1A6 and UGT1A9) are inducible by aryl hydrocarbon receptor agonists and even more isoforms (UGT1A6, UGT1A9, and UGT2B7) are inducible by antioxidant-type inducers in Caco-2 cells.
人结肠癌细胞Caco-2被用于研究芳烃受体激动剂以及抗氧化剂类诱导剂(分别为2,3,7,8-四氯二苯并对二恶英(TCDD)和叔丁基对苯二酚(TBHQ))对UDP葡萄糖醛酸基转移酶(UGT)同工型UGT1A6、UGT1A9和UGT2B7的诱导作用。分别选取了Caco-2细胞的早期传代克隆(PF11)和晚期传代克隆(TC7),它们分别表现出低水平和高水平的UGT1A6组成型表达。得到了以下结果:1)在Caco-2细胞中,10 nM TCDD或40至80 μM TBHQ可显著增强UGT活性(以4-甲基伞形酮为底物);2)双链逆转录-聚合酶链反应分析首次表明,40至80 μM TBHQ可增强人UGT1A6、UGT1A9和UGT2B7的表达;10 nM TCDD可诱导UGT1A6和UGT1A9,而TCDD不能诱导UGT2B7。结果表明,在Caco-2细胞中,至少两种人UGT(UGT